First Trust Advisors

First Trust Advisors’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

First Trust Advisors’s Portfolio NGM Stock Details NGM Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell
2021 Q4	$423K	Buy
2021 Q3	–	Sell
2021 Q2	$386K	Sell
2021 Q1	$2.95M	Buy
2020 Q4	–	Sell
2020 Q3	$1.1M	Buy